Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice

Physiological Genomics

Volumn 43, Issue 24, 2011, Pages 1351-1358

  Kõks, Sulev ^a   Soomets, Ursel ^a   Plaas, Mario ^a   Terasmaa, Anton ^a   Noormets, Klari ^a   Tillmann, Vallo ^a   Vasar, Eero ^a   Fernandes, Cathy ^b   Schalkwyk, Leonard C ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

C4b; Gene expression profiling; Hypothalamus; Rgs4; Wfs1 gene; Wolfram syndrome

Indexed keywords

COMPLEMENT COMPONENT C4B; GUANINE NUCLEOTIDE BINDING PROTEIN; RGS4 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CANONICAL ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; HYPOTHALAMUS; KNOCKOUT GENE; MALE; MOOD DISORDER; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WFS1 GENE; WOLFRAM SYNDROME;

ANIMALS; DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HYPOTHALAMUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 83655172512     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00117.2011     Document Type: Article

References (48)

1. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346: 1458-1463, 1995.
2. Berman DM, Wilkie TM, Gilman AG. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86: 445-452, 1996.
3. Bhuiyan T, Helmke S, Patel AR, Ruberg FL, Packman J, Cheung K, Grogan D, Maurer MS. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail 4: 121-128, 2010.
4. Brink BP, Veerhuis R, Breij EC, van der Valk P, Dijkstra CD, Bo L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 64: 147-155, 2005.
5. Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N, Pasquier F, Montoya AG, Peeters K, Mattheijssens M, Vandenberghe R, De Deyn PP, Cruts M, Amouyel P, Sleegers K, Van Broeckhoven C. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry [Epub ahead of print].
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
7. Cremers CW, Wijdeveld PG, Pinckers AJ. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl: 1-16, 1977.
8. Fonseca SG, Fukuma M, Lipson KL, Nguyen LX, Allen JR, Oka Y, Urano F. WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells. J Biol Chem 280: 39609-39615, 2005.
9. Gabreels BA, Swaab DF, de Kleijn DP, Dean A, Seidah NG, Van de Loo JW, Van de Ven WJ, Martens GJ, Van Leeuwen FW. The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J Clin Endocrinol Metab 83: 4026-4033, 1998.
10. Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C. MRI of Wolfram syndrome (DIDMOAD). Neuroradiology 41: 729-731, 1999.
11. Grafstein-Dunn E, Young KH, Cockett MI, Khawaja XZ. Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain. Brain Res Mol Brain Res 88: 113-123, 2001.
12. Guo X, Shen S, Song S, He S, Cui Y, Xing G, Wang J, Yin Y, Fan L, He F, Zhang L. The E3 ligase Smurf1 regulates Wolfram syndrome protein stability at the endoplasmic reticulum. J Biol Chem 2011.
13. Hayasaka N, Aoki K, Kinoshita S, Yamaguchi S, Wakefield JK, Tsuji-Kawahara S, Horikawa K, Ikegami H, Wakana S, Murakami T, Ramabhadran R, Miyazawa M, Shibata S. Attenuated food anticipatory activity and abnormal circadian locomotor rhythms in Rgs16 knockdown mice. PLoS One 6: e17655, 2011.
14. Hofmann S, Philbrook C, Gerbitz KD, Bauer MF. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 12: 2003-2012, 2003.
15. Horstman LL, Jy W, Ahn YS, Maghzi AH, Etemadifar M, Alexander JS, McGee JC, Minagar A. Complement in neurobiology. Front Biosci 17: 2921-2960, 2011.
16. Huuhka K, Kampman O, Anttila S, Huuhka M, Rontu R, Mattila KM, Hurme M, Lehtimaki T, Leinonen E. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder. Neu-rosci Lett 437: 25-28, 2008.
17. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comp Graph Stat 5: 299-314, 1996.
18. Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, Takei D, Yamada T, Inoue H, Soga H, Katagiri H, Tanizawa Y, Oka Y. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 13: 1159-1170, 2004.
19. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, Carroll MC, Verbeek JS, Botto M, Walport MJ, Molina H, Kalinke U, Acha-Orbea H, Aguzzi A. Complement facilitates early prion pathogenesis. Nat Med 7: 488-492, 2001.
20. Kõks S, Soomets U, Paya-Cano JL, Fernandes C, Luuk H, Plaas M, Terasmaa A, Tillmann V, Noormets K, Vasar E, Schalkwyk LC. Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiol Genomics 37: 249-259, 2009.
21. Lai E, Teodoro T, Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 22: 193-201, 2007.
22. Lane HY, Liu YC, Huang CL, Chang YC, Wu PL, Huang CH, Tsai GE. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. J Clin Psycho-pharmacol 28: 64-68, 2008.
23. Leontiadis LJ, Papakonstantinou MP, Georgoussi Z. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling. Cell Signal 21: 1218-1228, 2009.
24. Luuk H, Kõks S, Plaas M, Hannibal J, Rehfeld JF, Vasar E. Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome. J Comp Neurol 509: 642-660, 2008.
25. Luuk H, Plaas M, Raud S, Innos J, Sutt S, Lasner H, Abramov U, Kurrikoff K, Kõks S, Vasar E. Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behav Brain Res 198: 334-345, 2009.
26. Matto V, Terasmaa A, Vasar E, Koks S. Impaired striatal dopamine output of homozygous Wfs1 mutant mice in response to [K+] challenge. J Physiol Biochem 67: 53-60, 2010.
27. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107: 341-346, 1989.
28. Neubig RR, Siderovski DP. Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1: 187-197, 2002.
29. Noormets K, Kõks S, Kavak A, Arend A, Aunapuu M, Keldrimaa A, Vasar E, Tillmann V. Male mice with deleted Wolframin (Wfs1) gene have reduced fertility. Reprod Biol Endocrinol 7: 82, 2009.
30. Noormets K, Kõks S, Muldmaa M, Mauring L, Vasar E, Tillmann V. Sex differences in the development of diabetes in mice with deleted wolframin (Wfs1) gene. Exp Clin Endocrinol Diabetes 2010.
31. Osman AA, Saito M, Makepeace C, Permutt MA, Schlesinger P, Mueckler M. Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem 278: 52755-52762, 2003.
32. Pakdemirli E, Karabulut N, Bir LS, Sermez Y. Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome. Australas Radiol 49: 189-191, 2005.
33. Rando TA, Horton JC, Layzer RB. Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology 42: 1220-1224, 1992.
34. Riggs AC, Bernal-Mizrachi E, Ohsugi M, Wasson J, Fatrai S, Welling C, Murray J, Schmidt RE, Herrera PL, Permutt MA. Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 48: 2313-2321, 2005.
35. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 82: 510-529, 2004.
36. Scolding NJ, Kellar-Wood HF, Shaw C, Shneerson JM, Antoun N. Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol 39: 352-360, 1996.
37. So HC, Chen RY, Chen EY, Cheung EF, Li T, Sham PC. An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population. Am J Med Genet B Neuropsychiatr Genet 147B: 77-85, 2008.
38. Sousa MM, Saraiva MJ. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 71: 385-400, 2003.
39. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445, 2003.
40. Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, Rabl W, Gerbitz KD, Meitinger T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 7: 2021-2028, 1998.
41. Swift RG, Sadler DB, Swift M. Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336: 667-669, 1990.
42. Takei D, Ishihara H, Yamaguchi S, Yamada T, Tamura A, Katagiri H, Maruyama Y, Oka Y. WFS1 protein modulates the free Ca(2+) concentration in the endoplasmic reticulum. FEBS Lett 580: 5635-5640, 2006.
43. Torres AR, Maciulis A, Odell D. The association of MHC genes with autism. Front Biosci 6: D936-D943, 2001.
44. Trouw LA, Nielsen HM, Minthon L, Londos E, Landberg G, Veerhuis R, Janciauskiene S, Blom AM. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells. Mol Immunol 45: 3649-3660, 2008.
45. Villasenor A, Wang ZV, Rivera LB, Ocal O, Asterholm IW, Scherer PE, Brekken RA, Cleaver O, Wilkie TM. Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes. Dis Model Mech 3: 567-580, 2010.
46. Wang Q, Liu-Chen LY, Traynor JR. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells. J Biol Chem 284: 18357-18367, 2009.
47. Wolfram DJ, Wagener HP. Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin Proc 13: 715-718, 1938.
48. Yang NC, Lee MJ, Chao CC, Chuang YT, Lin WM, Chang MF, Hsieh PC, Kan HW, Lin YH, Yang CC, Chiu MJ, Liou HH, Hsieh ST. Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser. Neurology 75: 532-538, 2010.